Kim, Y., Kim, H., Park, D., Lee, H., Lee, Y. S., Choe, J., . . . Jeoung, D. (2017). The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3β and decreasing the expression of cyclinD1. Oncotarget.
Čikaški stil citiranjaKim, Youngmi, Hyuna Kim, Deokbum Park, Hansoo Lee, Yun Sil Lee, Jongseon Choe, Young Myeong Kim, Doyong Jeon, i Dooil Jeoung. "The Pentapeptide Gly-Thr-Gly-Lys-Thr Confers Sensitivity to Anti-cancer Drugs By Inhibition of CAGE Binding to GSK3β and Decreasing the Expression of CyclinD1." Oncotarget 2017.
MLA način citiranjaKim, Youngmi, et al. "The Pentapeptide Gly-Thr-Gly-Lys-Thr Confers Sensitivity to Anti-cancer Drugs By Inhibition of CAGE Binding to GSK3β and Decreasing the Expression of CyclinD1." Oncotarget 2017.